Prognosis

Gilead Virus Drug May Reduce Sperm Count in Mice: Chinese Study

Gilead Sciences Headquarters As Jumps To Two-Year High On Covid-19 Drug Hopes — Photographer: David Paul Morris/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Bloomberg News

April 26, 2020 at 5:53 AM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

A Gilead Sciences Inc. drug being tested as a potential treatment for Covid-19 may reduce the sperm count in mice, according to preliminary findings in a study by Chinese researchers.